Latest filing published 05 Sept 2017 for ALBANY MOLECULAR RESEARCH INC, €867k.
Insider track record
Christopher M. Conway: trading record in brief
Christopher M. Conway is a declared insider of Albany Molecular Research Inc, with filings sourced from SEC (Form 4). Between 31 January 2017 and 31 August 2017, the trades on record add up to 9 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 5 September 2017 came the latest disclosure, a share grant in Albany Molecular Research Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christopher M. Conway
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 47,477 shares@ US$21.7592.3% of flowCommon StockSEC:0001638599-17-000869:1
- 2,247 shares0Common StockSEC:0001638599-17-000869:0
- 271 shares@ US$14.520.4% of flowCommon StockSEC:0001144204-17-012951:0
- 4,278 shares0Common StockSEC:0001638599-17-000180:0
- 3,210 shares0Common StockSEC:0001638599-17-000180:1
- 1,900 shares@ US$18.523.5% of flowCommon StockSEC:0001638599-17-000160:0
- 553 shares@ US$18.521.0% of flowCommon StockSEC:0001638599-17-000160:1
- 491 shares@ US$18.520.9% of flowCommon StockSEC:0001638599-17-000160:2
- 1,061 shares@ US$18.111.9% of flowCommon StockSEC:0001638599-17-000134:0
9 of 9 declarations